Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Continuous Glucose Monitoring Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Continuous Glucose Monitoring Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Continuous Glucose Monitoring Business Mode and Production Process
2.3.1 Continuous Glucose Monitoring Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Continuous Glucose Monitoring Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Continuous Glucose Monitoring
2.4.2 Raw Material Cost of Continuous Glucose Monitoring
2.4.3 Labor Cost of Continuous Glucose Monitoring
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Continuous Glucose Monitoring Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Continuous Glucose Monitoring Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Continuous Glucose Monitoring Price by Manufacturer (2021-2026)
4.4 Continuous Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Continuous Glucose Monitoring, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Continuous Glucose Monitoring, Product Offered and Application
4.7 Continuous Glucose Monitoring Market Competitive Situation and Trends
4.7.1 Continuous Glucose Monitoring Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Continuous Glucose Monitoring Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Continuous Glucose Monitoring Market Historical Development by Geographic Region (2021-2026)
5.1 Global Continuous Glucose Monitoring Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Continuous Glucose Monitoring Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Continuous Glucose Monitoring Market Status by Country (2021-2026)
5.3.1 North America Continuous Glucose Monitoring Sales Volume by Country (2021-2026)
5.3.2 North America Continuous Glucose Monitoring Revenue by Country (2021-2026)
5.3.3 United States Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Continuous Glucose Monitoring Market Status by Country (2021-2026)
5.4.1 Europe Continuous Glucose Monitoring Sales Volume by Country (2021-2026)
5.4.2 Europe Continuous Glucose Monitoring Revenue by Country (2021-2026)
5.4.3 Germany Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Continuous Glucose Monitoring Market Status by Country (2021-2026)
5.5.1 Asia Pacific Continuous Glucose Monitoring Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Continuous Glucose Monitoring Revenue by Country (2021-2026)
5.5.3 China Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Continuous Glucose Monitoring Market Status by Country (2021-2026)
5.6.1 Latin America Continuous Glucose Monitoring Sales Volume by Country (2021-2026)
5.6.2 Latin America Continuous Glucose Monitoring Revenue by Country (2021-2026)
5.6.3 Mexico Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Continuous Glucose Monitoring Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Continuous Glucose Monitoring Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Continuous Glucose Monitoring Revenue by Country (2021-2026)
5.7.3 GCC Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
6 Global Continuous Glucose Monitoring Market Historical Development by Product Type (2021-2026)
6.1 Continuous Glucose Monitoring Definition by Type
6.2 Global Continuous Glucose Monitoring Historical Sales Volume by Product Type (2021-2026)
6.3 Global Continuous Glucose Monitoring Historical Revenue by Product Type (2021-2026)
6.4 Global Continuous Glucose Monitoring Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Transmitters (2021-2026)
6.5.2 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Sensors (2021-2026)
6.5.3 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Receivers (2021-2026)
7 Global Continuous Glucose Monitoring Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Continuous Glucose Monitoring Historical Sales Volume by End User (2021-2026)
7.3 Global Continuous Glucose Monitoring Historical Revenue by End User (2021-2026)
7.4 Global Continuous Glucose Monitoring Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Hospitals (2021-2026)
7.5.2 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Home Care (2021-2026)
7.5.3 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)
8 Leading Companies Profiles
8.1 Echo Therapeutics, Inc.
8.1.1 Echo Therapeutics, Inc. Corporation Information
8.1.2 Echo Therapeutics, Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.1.3 Echo Therapeutics, Inc. Performance Analysis (2021-2026)
8.1.4 Echo Therapeutics, Inc. Business and Markets Served
8.1.5 Echo Therapeutics, Inc. Recent Developments
8.2 Novo Nordisk
8.2.1 Novo Nordisk Corporation Information
8.2.2 Novo Nordisk - Continuous Glucose Monitoring Product Portfolio and Specification
8.2.3 Novo Nordisk Performance Analysis (2021-2026)
8.2.4 Novo Nordisk Business and Markets Served
8.2.5 Novo Nordisk Recent Developments
8.3 Ypsomed
8.3.1 Ypsomed Corporation Information
8.3.2 Ypsomed - Continuous Glucose Monitoring Product Portfolio and Specification
8.3.3 Ypsomed Performance Analysis (2021-2026)
8.3.4 Ypsomed Business and Markets Served
8.3.5 Ypsomed Recent Developments
8.4 Animas Corporation
8.4.1 Animas Corporation Corporation Information
8.4.2 Animas Corporation - Continuous Glucose Monitoring Product Portfolio and Specification
8.4.3 Animas Corporation Performance Analysis (2021-2026)
8.4.4 Animas Corporation Business and Markets Served
8.4.5 Animas Corporation Recent Developments
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Corporation Information
8.5.2 Johnson & Johnson - Continuous Glucose Monitoring Product Portfolio and Specification
8.5.3 Johnson & Johnson Performance Analysis (2021-2026)
8.5.4 Johnson & Johnson Business and Markets Served
8.5.5 Johnson & Johnson Recent Developments
8.6 Pfizer Inc.
8.6.1 Pfizer Inc. Corporation Information
8.6.2 Pfizer Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.6.3 Pfizer Inc. Performance Analysis (2021-2026)
8.6.4 Pfizer Inc. Business and Markets Served
8.6.5 Pfizer Inc. Recent Developments
8.7 Dexcom, Inc.
8.7.1 Dexcom, Inc. Corporation Information
8.7.2 Dexcom, Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.7.3 Dexcom, Inc. Performance Analysis (2021-2026)
8.7.4 Dexcom, Inc. Business and Markets Served
8.7.5 Dexcom, Inc. Recent Developments
8.8 Insulet Corporation
8.8.1 Insulet Corporation Corporation Information
8.8.2 Insulet Corporation - Continuous Glucose Monitoring Product Portfolio and Specification
8.8.3 Insulet Corporation Performance Analysis (2021-2026)
8.8.4 Insulet Corporation Business and Markets Served
8.8.5 Insulet Corporation Recent Developments
8.9 Senseonics Holdings, Inc.
8.9.1 Senseonics Holdings, Inc. Corporation Information
8.9.2 Senseonics Holdings, Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.9.3 Senseonics Holdings, Inc. Performance Analysis (2021-2026)
8.9.4 Senseonics Holdings, Inc. Business and Markets Served
8.9.5 Senseonics Holdings, Inc. Recent Developments
8.10 Medtronic, Inc.
8.10.1 Medtronic, Inc. Corporation Information
8.10.2 Medtronic, Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.10.3 Medtronic, Inc. Performance Analysis (2021-2026)
8.10.4 Medtronic, Inc. Business and Markets Served
8.10.5 Medtronic, Inc. Recent Developments
8.11 Abbott Laboratories
8.11.1 Abbott Laboratories Corporation Information
8.11.2 Abbott Laboratories - Continuous Glucose Monitoring Product Portfolio and Specification
8.11.3 Abbott Laboratories Performance Analysis (2021-2026)
8.11.4 Abbott Laboratories Business and Markets Served
8.11.5 Abbott Laboratories Recent Developments
8.12 Baxter International Inc.
8.12.1 Baxter International Inc. Corporation Information
8.12.2 Baxter International Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.12.3 Baxter International Inc. Performance Analysis (2021-2026)
8.12.4 Baxter International Inc. Business and Markets Served
8.12.5 Baxter International Inc. Recent Developments
8.13 GlySens Incorporated
8.13.1 GlySens Incorporated Corporation Information
8.13.2 GlySens Incorporated - Continuous Glucose Monitoring Product Portfolio and Specification
8.13.3 GlySens Incorporated Performance Analysis (2021-2026)
8.13.4 GlySens Incorporated Business and Markets Served
8.13.5 GlySens Incorporated Recent Developments
8.14 F. Hoffmann-La Roche Ltd.
8.14.1 F. Hoffmann-La Roche Ltd. Corporation Information
8.14.2 F. Hoffmann-La Roche Ltd. - Continuous Glucose Monitoring Product Portfolio and Specification
8.14.3 F. Hoffmann-La Roche Ltd. Performance Analysis (2021-2026)
8.14.4 F. Hoffmann-La Roche Ltd. Business and Markets Served
8.14.5 F. Hoffmann-La Roche Ltd. Recent Developments
8.15 A. Menarini Diagnostics
8.15.1 A. Menarini Diagnostics Corporation Information
8.15.2 A. Menarini Diagnostics - Continuous Glucose Monitoring Product Portfolio and Specification
8.15.3 A. Menarini Diagnostics Performance Analysis (2021-2026)
8.15.4 A. Menarini Diagnostics Business and Markets Served
8.15.5 A. Menarini Diagnostics Recent Developments
9 Global Continuous Glucose Monitoring Market Forecast by Product Type and End User (2026-2034)
9.1 Global Continuous Glucose Monitoring Market Forecast by Product Type (2026-2034)
9.1.1 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Transmitters (2026-2034)
9.1.2 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Sensors (2026-2034)
9.1.3 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Receivers (2026-2034)
9.2 Global Continuous Glucose Monitoring Market Forecast by End User (2026-2034)
9.2.1 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Hospitals (2026-2034)
9.2.2 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Home Care (2026-2034)
9.2.3 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
10 Global Continuous Glucose Monitoring Market Forecast by Geographic Region (2026-2034)
10.1 Global Continuous Glucose Monitoring Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Continuous Glucose Monitoring Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Continuous Glucose Monitoring Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Continuous Glucose Monitoring Business Mode and Production Process
2.3.1 Continuous Glucose Monitoring Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Continuous Glucose Monitoring Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Continuous Glucose Monitoring
2.4.2 Raw Material Cost of Continuous Glucose Monitoring
2.4.3 Labor Cost of Continuous Glucose Monitoring
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Continuous Glucose Monitoring Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Continuous Glucose Monitoring Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Continuous Glucose Monitoring Price by Manufacturer (2021-2026)
4.4 Continuous Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Continuous Glucose Monitoring, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Continuous Glucose Monitoring, Product Offered and Application
4.7 Continuous Glucose Monitoring Market Competitive Situation and Trends
4.7.1 Continuous Glucose Monitoring Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Continuous Glucose Monitoring Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Continuous Glucose Monitoring Market Historical Development by Geographic Region (2021-2026)
5.1 Global Continuous Glucose Monitoring Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Continuous Glucose Monitoring Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Continuous Glucose Monitoring Market Status by Country (2021-2026)
5.3.1 North America Continuous Glucose Monitoring Sales Volume by Country (2021-2026)
5.3.2 North America Continuous Glucose Monitoring Revenue by Country (2021-2026)
5.3.3 United States Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Continuous Glucose Monitoring Market Status by Country (2021-2026)
5.4.1 Europe Continuous Glucose Monitoring Sales Volume by Country (2021-2026)
5.4.2 Europe Continuous Glucose Monitoring Revenue by Country (2021-2026)
5.4.3 Germany Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Continuous Glucose Monitoring Market Status by Country (2021-2026)
5.5.1 Asia Pacific Continuous Glucose Monitoring Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Continuous Glucose Monitoring Revenue by Country (2021-2026)
5.5.3 China Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Continuous Glucose Monitoring Market Status by Country (2021-2026)
5.6.1 Latin America Continuous Glucose Monitoring Sales Volume by Country (2021-2026)
5.6.2 Latin America Continuous Glucose Monitoring Revenue by Country (2021-2026)
5.6.3 Mexico Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Continuous Glucose Monitoring Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Continuous Glucose Monitoring Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Continuous Glucose Monitoring Revenue by Country (2021-2026)
5.7.3 GCC Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Continuous Glucose Monitoring Sales Volume, Revenue and Growth (2021-2026)
6 Global Continuous Glucose Monitoring Market Historical Development by Product Type (2021-2026)
6.1 Continuous Glucose Monitoring Definition by Type
6.2 Global Continuous Glucose Monitoring Historical Sales Volume by Product Type (2021-2026)
6.3 Global Continuous Glucose Monitoring Historical Revenue by Product Type (2021-2026)
6.4 Global Continuous Glucose Monitoring Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Transmitters (2021-2026)
6.5.2 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Sensors (2021-2026)
6.5.3 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Receivers (2021-2026)
7 Global Continuous Glucose Monitoring Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Continuous Glucose Monitoring Historical Sales Volume by End User (2021-2026)
7.3 Global Continuous Glucose Monitoring Historical Revenue by End User (2021-2026)
7.4 Global Continuous Glucose Monitoring Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Hospitals (2021-2026)
7.5.2 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Home Care (2021-2026)
7.5.3 Global Continuous Glucose Monitoring Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)
8 Leading Companies Profiles
8.1 Echo Therapeutics, Inc.
8.1.1 Echo Therapeutics, Inc. Corporation Information
8.1.2 Echo Therapeutics, Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.1.3 Echo Therapeutics, Inc. Performance Analysis (2021-2026)
8.1.4 Echo Therapeutics, Inc. Business and Markets Served
8.1.5 Echo Therapeutics, Inc. Recent Developments
8.2 Novo Nordisk
8.2.1 Novo Nordisk Corporation Information
8.2.2 Novo Nordisk - Continuous Glucose Monitoring Product Portfolio and Specification
8.2.3 Novo Nordisk Performance Analysis (2021-2026)
8.2.4 Novo Nordisk Business and Markets Served
8.2.5 Novo Nordisk Recent Developments
8.3 Ypsomed
8.3.1 Ypsomed Corporation Information
8.3.2 Ypsomed - Continuous Glucose Monitoring Product Portfolio and Specification
8.3.3 Ypsomed Performance Analysis (2021-2026)
8.3.4 Ypsomed Business and Markets Served
8.3.5 Ypsomed Recent Developments
8.4 Animas Corporation
8.4.1 Animas Corporation Corporation Information
8.4.2 Animas Corporation - Continuous Glucose Monitoring Product Portfolio and Specification
8.4.3 Animas Corporation Performance Analysis (2021-2026)
8.4.4 Animas Corporation Business and Markets Served
8.4.5 Animas Corporation Recent Developments
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Corporation Information
8.5.2 Johnson & Johnson - Continuous Glucose Monitoring Product Portfolio and Specification
8.5.3 Johnson & Johnson Performance Analysis (2021-2026)
8.5.4 Johnson & Johnson Business and Markets Served
8.5.5 Johnson & Johnson Recent Developments
8.6 Pfizer Inc.
8.6.1 Pfizer Inc. Corporation Information
8.6.2 Pfizer Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.6.3 Pfizer Inc. Performance Analysis (2021-2026)
8.6.4 Pfizer Inc. Business and Markets Served
8.6.5 Pfizer Inc. Recent Developments
8.7 Dexcom, Inc.
8.7.1 Dexcom, Inc. Corporation Information
8.7.2 Dexcom, Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.7.3 Dexcom, Inc. Performance Analysis (2021-2026)
8.7.4 Dexcom, Inc. Business and Markets Served
8.7.5 Dexcom, Inc. Recent Developments
8.8 Insulet Corporation
8.8.1 Insulet Corporation Corporation Information
8.8.2 Insulet Corporation - Continuous Glucose Monitoring Product Portfolio and Specification
8.8.3 Insulet Corporation Performance Analysis (2021-2026)
8.8.4 Insulet Corporation Business and Markets Served
8.8.5 Insulet Corporation Recent Developments
8.9 Senseonics Holdings, Inc.
8.9.1 Senseonics Holdings, Inc. Corporation Information
8.9.2 Senseonics Holdings, Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.9.3 Senseonics Holdings, Inc. Performance Analysis (2021-2026)
8.9.4 Senseonics Holdings, Inc. Business and Markets Served
8.9.5 Senseonics Holdings, Inc. Recent Developments
8.10 Medtronic, Inc.
8.10.1 Medtronic, Inc. Corporation Information
8.10.2 Medtronic, Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.10.3 Medtronic, Inc. Performance Analysis (2021-2026)
8.10.4 Medtronic, Inc. Business and Markets Served
8.10.5 Medtronic, Inc. Recent Developments
8.11 Abbott Laboratories
8.11.1 Abbott Laboratories Corporation Information
8.11.2 Abbott Laboratories - Continuous Glucose Monitoring Product Portfolio and Specification
8.11.3 Abbott Laboratories Performance Analysis (2021-2026)
8.11.4 Abbott Laboratories Business and Markets Served
8.11.5 Abbott Laboratories Recent Developments
8.12 Baxter International Inc.
8.12.1 Baxter International Inc. Corporation Information
8.12.2 Baxter International Inc. - Continuous Glucose Monitoring Product Portfolio and Specification
8.12.3 Baxter International Inc. Performance Analysis (2021-2026)
8.12.4 Baxter International Inc. Business and Markets Served
8.12.5 Baxter International Inc. Recent Developments
8.13 GlySens Incorporated
8.13.1 GlySens Incorporated Corporation Information
8.13.2 GlySens Incorporated - Continuous Glucose Monitoring Product Portfolio and Specification
8.13.3 GlySens Incorporated Performance Analysis (2021-2026)
8.13.4 GlySens Incorporated Business and Markets Served
8.13.5 GlySens Incorporated Recent Developments
8.14 F. Hoffmann-La Roche Ltd.
8.14.1 F. Hoffmann-La Roche Ltd. Corporation Information
8.14.2 F. Hoffmann-La Roche Ltd. - Continuous Glucose Monitoring Product Portfolio and Specification
8.14.3 F. Hoffmann-La Roche Ltd. Performance Analysis (2021-2026)
8.14.4 F. Hoffmann-La Roche Ltd. Business and Markets Served
8.14.5 F. Hoffmann-La Roche Ltd. Recent Developments
8.15 A. Menarini Diagnostics
8.15.1 A. Menarini Diagnostics Corporation Information
8.15.2 A. Menarini Diagnostics - Continuous Glucose Monitoring Product Portfolio and Specification
8.15.3 A. Menarini Diagnostics Performance Analysis (2021-2026)
8.15.4 A. Menarini Diagnostics Business and Markets Served
8.15.5 A. Menarini Diagnostics Recent Developments
9 Global Continuous Glucose Monitoring Market Forecast by Product Type and End User (2026-2034)
9.1 Global Continuous Glucose Monitoring Market Forecast by Product Type (2026-2034)
9.1.1 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Transmitters (2026-2034)
9.1.2 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Sensors (2026-2034)
9.1.3 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Receivers (2026-2034)
9.2 Global Continuous Glucose Monitoring Market Forecast by End User (2026-2034)
9.2.1 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Hospitals (2026-2034)
9.2.2 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Home Care (2026-2034)
9.2.3 Global Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
10 Global Continuous Glucose Monitoring Market Forecast by Geographic Region (2026-2034)
10.1 Global Continuous Glucose Monitoring Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Continuous Glucose Monitoring Sales Volume, Revenue Forecast and Growth (2026-2034)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer